View Study Goldstein, A.L., et al
Lyophilised GHK-Cu powder (unreconstituted) is stable at 20C because water is absent, but once the peptide is in solution or cream base, freezing damages it irreversibly
These compounds are not approved for human or veterinary use unless specifically noted in an approved drug context, such as tesamorelin for HIV-associated lipodystrophy
This consideration exists independently of GLP-1 use and should be discussed with a physician
Response monitoring should include subjective symptom tracking, functional assessments, and appropriate objective measures
In the Phase 3 REDEFINE 1 trial, cagrilintide monotherapy achieved 11.8% average weight loss over 68 weekscomparable to semaglutide but with a notably lower incidence of nausea and vomiting, making it a potential option for patients who dont tolerate GLP-1 medications well